CoverageForm 410-K10-Q8-K13D13G13F

Processa Pharmaceuticals, Inc.

PCSACIK 0001533743 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback
Full filing:tone -0.0040

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Top insiders

Most active reporters at Processa Pharmaceuticals, Inc.

NameRolesFilings
Floyd Robert Michael
Officer
7
Neal James R
Director
6
Thompson Virgil
Director
4
Islam Khalid
Director
2

Showing 11-14 of 14

PrevPage 3 of 3

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Processa Pharmaceuticals, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#InsiderTradesWin rateAvgMedianBestWorst
1Yorke Justin W333%-21.5%-22.2%+19.3%-61.6%
2Young David850%-11.1%+1.5%+15.0%-61.6%
3Lin Patrick714%-4.5%-7.9%+72.5%-61.6%

All filings

180 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue